The efficacy and safety of anlotinib plus PD-1 blockades in patients with advanced non-small cell lung can- cer previously treated with immunotherapy

WU Yang; LU Hanjie; SHUI Huifeng

doi:10.3969/j.issn.1006-5725.2023.05.008

Home>Articles>The efficacy and safety of anlotinib plus PD-1 blockades in patients with advanced non-small cell lung can- cer previously treated with immunotherapy

DOI: 10.3969/j.issn.1006-5725.2023.05.008

The efficacy and safety of anlotinib plus PD-1 blockades in patients with advanced non-small cell lung can- cer previously treated with immunotherapy

WU Yang

LU Hanjie

SHUI Huifeng

Machine-generated Keywords：

Publication Date：2023-03-10

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：7( 572-578 )

The Journal of Practical Medicine

ISTICPKU

ISSN：1006-5725

Year, Vol.(Issue)：2023,39(5)